|
Group
|
Bout
|
WBC (103/μL)
|
Neutrophil Percent
|
Neutrophil Count (103/μL)
|
Lymphocyte Percent
|
Lymphocyte Count (103/μL)
|
Monocyte Percent
|
Monocyte Count (103/μL)
|
|---|
|
BCAA-CHO
|
T1
|
6.51 ± 0.35
|
55.46 ± 2.45
|
3.64 ± 0.28
|
34.06 ± 2.41
|
2.03 ± 0.13
|
7.18 ± 0.32
|
0.49 ± 0.04
|
|
24 h post bout 1
|
6.19 ± 0.26
|
56.77 ± 1.96
|
3.52 ± 0.21
|
31.79 ± 1.38
|
2.04 ± 0.15
|
7.48 ± 0.33
|
0.47 ± 0.03
|
|
24 h post bout 2
|
6.43 ± 0.26
|
58.35 ± 2.51
|
3.97 ± 0.31
|
32.11 ± 2.33
|
1.89 ± 0.19
|
6.86 ± 0.31
|
0.44 ± 0.03
|
|
48 h post bout 3 (T2)
|
6.56 ± 0.37
|
57.26 ± 1.81
|
3.69 ± 0.29
|
31.21 ± 1.90
|
1.98 ± 0.10
|
7.25 ± 0.24
|
0.49 ± 0.03
|
|
CHO
|
T1
|
6.44 ± 0.35
|
55.43 ± 2.59
|
3.53 ± 0.29
|
32.61 ± 2.03
|
2.11 ± 0.12
|
8.21 ± 0.45
|
0.57 ± 0.03
|
|
24 h post bout 1
|
5.85 ± 0.32
|
53.54 ± 2.24
|
3.20 ± 0.28
|
32.43 ± 2.35
|
1.91 ± 0.12
|
8.75 ± 0.52
‡
|
0.50 ± 0.03
|
|
24 h post bout 2
|
5.81 ± 0.33
|
53.18 ± 2.92
|
3.05 ± 0.28
|
33.76 ± 2.79
|
1.90 ± 0.13
|
9.16 ± 0.40
‡
|
0.55 ± 0.03
|
|
48 h post bout 3 (T2)
|
6.21 ± 0.32
|
53.15 ± 2.06
|
3.34 ± 0.24
|
30.37 ± 2.14
|
1.90 ± 0.12
|
9.15 ± 0.38
‡†
|
0.59 ± 0.03
|
-
Abbreviations BCAA-CHO branched-chain amino acid and carbohydrate-supplemented group, CHO carbohydrate only-supplemented group
- Analysis of monocyte percentages revealed a group*time interaction (p = 0.01) whereby BCAA-CHO supplementation attenuated increases in monocyte percentages 24 h following bout 1 (p = 0.049), 24 h following bout 2 (p < 0.001), and 48 h following bout 3 (or at T2; p < 0.001) compared to CHO supplementation (denoted by bold lettering and superscript ‡ symbol). Moreover, T2 monocyte percentages increased within the CHO group at T2 compared to T1 (denoted by superscript † symbol, p = 0.012)
